BlackRock Fund Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $87.5M | Buy |
2,663,371
+372,992
| +16% | +$12.2M | 0.02% | 1307 |
|
|
2016
Q3 | $72.2M | Buy |
2,290,379
+285,152
| +14% | +$8.99M | 0.01% | 1326 |
|
|
2016
Q2 | $56.4M | Buy |
2,005,227
+114,715
| +6% | +$3.23M | 0.01% | 1406 |
|
|
2016
Q1 | $68.7M | Sell |
1,890,512
-12,043
| -0.6% | -$438K | 0.02% | 1237 |
|
|
2015
Q4 | $76.1M | Buy |
1,902,555
+107,633
| +6% | +$4.31M | 0.02% | 1179 |
|
|
2015
Q3 | $51.1M | Buy |
1,794,922
+62,943
| +4% | +$1.79M | 0.01% | 1409 |
|
|
2015
Q2 | $57.1M | Buy |
1,731,979
+32,165
| +2% | +$1.06M | 0.01% | 1434 |
|
|
2015
Q1 | $48.9M | Buy |
1,699,814
+99,056
| +6% | +$2.85M | 0.01% | 1519 |
|
|
2014
Q4 | $43.6M | Buy |
1,600,758
+149,456
| +10% | +$4.07M | 0.01% | 1549 |
|
|
2014
Q3 | $30.9M | Sell |
1,451,302
-48,298
| -3% | -$1.03M | 0.01% | 1670 |
|
|
2014
Q2 | $33.7M | Sell |
1,499,600
-36,113
| -2% | -$811K | 0.01% | 1672 |
|
|
2014
Q1 | $38.8M | Sell |
1,535,713
-130
| -0% | -$3.29K | 0.01% | 1575 |
|
|
2013
Q4 | $35.3M | Buy |
1,535,843
+45,430
| +3% | +$1.04M | 0.01% | 1633 |
|
|
2013
Q3 | $28.4M | Buy |
1,490,413
+192,053
| +15% | +$3.66M | 0.01% | 1732 |
|
|
2013
Q2 | $18.7M | Buy |
+1,298,360
| New | +$18.7M | 0.01% | 1899 |
|